RTCT raises hard questions about sponsor liability, blinding integrity, DSMB overlap, and AI accountability that the industry hasn’t yet resolved. Both sides of that ledger deserve honest consideration.
- Pharma's Digital Transformation: Where It's Really At
- How AI Is Changing Clinical Trial Design, Not Just Speed
- What Is Clinical Trials Day? Why Technology Helps Research Rise
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Why Are Life Science Companies So Poorly Prepared For RIM's Future?
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
ON-DEMAND WEBINARS
CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.
AI has great potential to enhance the efforts of your team members by accelerating data interactions. Watch this webinar and discover how AI can improve clinical trial outcomes and data management.
Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.
In this session of Digital Health Monthly, Dr. Glenn Gaesser shares his extensive research on the intersection of obesity and exercise physiology, emphasizing the importance of physical activity.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-2156796837 cancer patient tablet]( "Bring Your Own Device (BYOD) Clinical Trials")
Bring Your Own Device (BYOD) Clinical TrialsBring Your Own Device (BYOD) is revolutionizing clinical trials by enabling participants and researchers to use their own smartphones, tablets, or computers to collect and manage data.
-
![GettyImages-835429430 doctors computer]( "Automation, Analytics, AI, And The Future Of Trial Monitoring")
Automation, Analytics, AI, And The Future Of Trial MonitoringMore teams are utilizing AI and automation to recruit and retain more patients. Discover how predictive analytics allow clinical trial teams to make better prognostications about patient behavior.
-
![GettyImages-1314299046 econsent]( "Preparing Studies With eConsent For IRB Approval")
Preparing Studies With eConsent For IRB ApprovalUnderstand how eConsent can benefit trials and align with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models.
-
![AI-Artificial Intelligence in Healthcare-GettyImages-1365534802]( "Digital Advancements In Clinical Development - What's Next?")
Digital Advancements In Clinical Development - What's Next?Review this year's predictions for improving digital biomarkers and data analytics, bettering endpoint sensitivity and specificity, and reducing timelines and costs of clinical development.
-
![GettyImages-1385471311 patient tablet]( "Revolutionizing Pediatric Clinical Trials With ePRO And eConsent")
Revolutionizing Pediatric Clinical Trials With ePRO And eConsentDigital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.
-
![GettyImages-1182436133 scientist, lab, research, oncology]( "How Real-World Data On Site Costs Accelerates Clinical Trial Success")
How Real-World Data On Site Costs Accelerates Clinical Trial SuccessOutdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.
-
![AI Artificial Intelligence-GettyImages-1209787439]( "Growing Pains: The Real Story Behind Gen AI Development In Clinical Trial Ops")
Growing Pains: The Real Story Behind Gen AI Development In Clinical Trial OpsAs Gen AI develops and reaches advanced stages it introduces risks such as model hallucinations, which can affect trial accuracy and reliability. Explore how to address these challenges.
-
![Virtual Covid 19 Clinical Trial]( "Endpoint Reliability And eCOA Solutions Facilitate CNS Trial Success")
Endpoint Reliability And eCOA Solutions Facilitate CNS Trial SuccessA Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.
-
![GettyImages-1468153601-regulation-honeycomb-hand-target]( "Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals")
Understanding Decentralized Clinical Trials: FDA vs. EMA FundamentalsDesigning a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.
-
![business growth iStock-1274437411]( "Expanding Flexibility Of eCOA Data Collection With Controlled Interview Mode")
Expanding Flexibility Of eCOA Data Collection With Controlled Interview ModeDiscover how the interview mode constitutes an additional data entry mode for ePROs when clinical trial participants cannot go to the study site for a scheduled visit.
RECENT NEWSLETTERS
- 06.04.26 -- Why Clinical Execution — Not Tech — Is Trials' Biggest Risk
- 05.28.26 -- FDA's Elsa AI Shift, RTCT Rules, And RWE That Works
- 05.21.26 -- AI, HEOR, And Hidden Costs Reshaping Clinical Trials
- 05.14.26 -- AI, RWE, And The Systems Breaking Clinical Trials
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
